Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation Plans (Tables)

v3.3.1.900
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Outstanding Awards Under 2013 Omnibus Equity Incentive Plan

Activity under the 2013 Plan consisted of the following (dollars in thousands, except per share data):

 

     RSA Grants to
Non-employee
Directors
    RSU Grants to
Employees
    RSU Grants to
Independent
Contractors
    Total     Weighted-
Average Grant
Date Fair Value
Per Share
 

Nonvested shares at December 31, 2013

     30,000        313,155        570,760        913,915      $ 14.46   

Granted

          

February 2014

     —          —          38,088        38,088     

May 2014

     22,884        6,991        31,780        61,655     

August 2014

     —          6,346        12,474        18,820     

November 2014

     —          9,584        4,638        14,222     

December 2014

     —          216,411        —          216,411     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Granted

     22,884        239,332        86,980        349,196        27.46   

Vested

     (10,002     —          —          (10,002     12.00   

Transferred

     —          (8,596     8,596        —          14.54   

Forfeited/canceled

     —          (27,454     (18,646     (46,100     14.65   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nonvested shares at December 31, 2014 (1)

     42,882        516,437        647,690        1,207,009      $ 18.23   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Granted

          

February 2015

     —          15,847        9,720        25,567     

May 2015

     10,110        8,142        4,212        22,464     

August 2015

     —          5,607        25,148        30,755     

November 2015

     —          2,117        7,805        9,922     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Granted

     10,110        31,713        46,885        88,708        42.91   

Vested

     (17,628     (57,711     (138,119     (213,458     14.90   

Transferred

     —          (8,423     8,423        —          17.81   

Forfeited/canceled

     —          (13,047     (43,099     (56,146     16.29   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nonvested shares at December 31, 2015 (1)

     35,364        468,969        521,780        1,026,113      $ 21.17   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unrecognized stock-based compensation expense as of December 31, 2015 (2)

   $ 543      $ 8,698      $ 11,180      $ 20,421     
  

 

 

   

 

 

   

 

 

   

 

 

   

Weighted average remaining vesting period (years) as of December 31, 2015

     1.77        3.80        3.20        3.42     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

(1)  Nonvested RSU’s will be settled through the issuance of new shares of common stock.
(2)  The total unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately 3.42 years.
Summary of Stock Option Activity - Pre-IPO

MMREIS’s stock option activity consisted of the following:

 

     Year Ended
December 31, 2013
 
     Shares
Under
Options
     Weighted-
Average
Exercise
Price
 

Options outstanding at beginning of year:

     750       $ 28.86   

Granted

     —           —     

Exercised

     (750      28.86   
  

 

 

    

 

 

 

Options outstanding at end of year

     —         $ —     
  

 

 

    

 

 

 
Summary of Restricted Common Stock Activity - Pre - IPO

MMREIS’s restricted common stock activity consisted of the following:

 

     Year Ended
December 31, 2013
 
     Restricted
Stock
     Weighted
Average
Grant
Date Fair
Value
 

Restricted common stock outstanding at beginning of year:

     27,999       $ 23.67   

Issued upon exercise of stock options

     750         28.86   

Exchange of common stock(1)

     (28,749      —     
  

 

 

    

 

 

 

Restricted common stock outstanding at end of year

     —         $ —     
  

 

 

    

 

 

 

Restricted common stock vested at end of year

     —        

Restricted common stock unvested at end of year

     —        

 

(1)  Exchanged for new Marcus & Millichap stock prior to the IPO. Refer to Note 9 – “Stockholders’ Equity” for additional information on the exchange of common stock.
Summary of SARs Activity - Pre - IPO

MMREIS’s SARs activity consisted of the following:

 

     Year Ended
December 31,
2013
 

SARs outstanding at beginning of period:

     28,733   

Granted

     —     

Settled (1)

     (28,733
  

 

 

 

SARs outstanding at end of period

     —     
  

 

 

 

SARs vested at end of period

     —     
  

 

 

 

 

(1)  Prior to the IPO, outstanding SAR’s were settled by exchanging the SAR’s for DSU’s for 2,192,413 shares of the new Marcus & Millichap common stock and a fixed SAR’s liability amount. SeeAmendments to Restricted Stock and SARs below.
Stock-Based Compensation Expense

Components of stock-based compensation included in selling, general and administrative expense in the consolidated statements of net and comprehensive income consisted of the following (in thousands, except common stock price):

 

     Year Ended December 31,  
     2015      2014      2013  

Restricted stock and SARs (prior to IPO)

   $ —         $ —         $ 4,679   

Stock based compensation in connection with IPO

     —           —           30,886   

Employee stock purchase plan

     285         128         —     

RSAs – non-employee directors

     319         197         20   

RSUs - employees

     2,351         817         88   

RSUs – independent contractors (1)

     4,159         3,892         168   
  

 

 

    

 

 

    

 

 

 
   $ 7,114       $ 5,034       $ 35,841   
  

 

 

    

 

 

    

 

 

 
Changes in Company's Common Stock Price During Reporting Period

Common stock price at beginning of period

   $ 33.25       $ 14.90       $ —     

Common stock price at end of period

   $ 29.14       $ 33.25       $ 14.90   

(Decrease) increase in stock price

   $ (4.11    $ 18.35       $ n/a